FDA Inspection 1264907 — LTS Lohmann Therapie-Systeme AG

LTS Lohmann Therapie-Systeme AG — FEI 3003387535

The FDA completed an inspection of LTS Lohmann Therapie-Systeme AG on May 18, 2022 in Andernach. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 18, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Andernach (Germany)

Additional Details

Mutual Recognition Agreement (MRA)